期刊文献+

血脂检测在肝脏疾病诊断中的临床意义 被引量:2

The Detection of Serum Lipids and Its Value in the Diagnosis of Hepatic Diseases
下载PDF
导出
摘要 目的观察各种肝脏疾病血脂水平的变化,探讨其在疾病诊断中的意义。方法采用全自动生化分析仪分别检测本院76例脂肪肝、138例病毒性肝炎、45例肝硬化及39例肝癌患者血脂(甘油三酯TG、总胆固醇TC、高密度脂蛋白胆固醇HDL-C、低密度脂蛋白胆固醇LDL-C及载脂蛋白A1和B)的浓度,与95例健康体检者作比较。结果 与正常对照组相比,病毒性肝炎、肝硬化及肝癌患者TG、TC、HDL-C、LDL-C、apoA1及apoB浓度均有下降,差异具有统计学意义(P<0.05或P<0.01);脂肪肝患者除HDL-C和apoA1有显著性下降外,其余指标水平及阳性率均比正常组升高,差异具有统计学意义(P<0.01)。结论检测血脂水平对诊断各种肝脏疾病有临床价值,可以了解肝实质损伤的程度。 Objective To evaluate the value of the diagnosis of serum lipids in hepatic diseases. Methods The concentration of serum lipids (TG,TC,HDL-C,LDL-C,apoA1 and apoB) in the hepatic diseases patients in our hospital was detected by the automatic biochemical analyzer,including 76 cases of fatty hver, 138 cases of virus hepatitis,45 cases of cirrhosis and 39 cases of hepatic carcinoma. The results were compared with the control group. Results Comparing with the control group, the concentration of serum lipids of virus hepatitis,cirrhosis and hepatic carcinoma were remarkably decreased(P〈0.05 or 0.01). The HDL-C and apoA1 of Fatty Liver were remarkably increased and the other markers were remarkably decreased (P〈0.01). Conclusion The detection of serum lipids could be used to diagnose hepatic diseases.
作者 王辉
出处 《中国现代医生》 2011年第18期136-137,共2页 China Modern Doctor
关键词 肝脏疾病 血脂 肝实质 Hepatic diseases Serum lipids Liver parenchyma
  • 相关文献

参考文献6

二级参考文献40

  • 1刘梅颜,胡大一.高尿酸血症与高甘油三酯血症对冠状动脉风险的联合评估价值[J].中国综合临床,2006,22(3):193-195. 被引量:28
  • 2王威,江海涛,李玉红,茹永新,高秀梅,张伯礼.脂肪肝发病机制研究进展[J].天津中医药,2006,23(2):169-171. 被引量:9
  • 3赵兰江,赵冬.尿酸代谢异常与甘油三酯代谢异常的关系[J].中华流行病学杂志,2006,27(4):362-365. 被引量:36
  • 4罗荣高,杨兴仁,李东升.脂肪肝与血脂的关系探讨[J].临床军医杂志,2006,34(3):302-302. 被引量:22
  • 5Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome:an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement[J]. Circulation, 2005,112 (17) : 2735-2752.
  • 6Buse JB, Ginsberg HN, Bakris GL, et al, Primary preven tion of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Associa tion and the American Diabetes Association[J].Circulation 2007,115(1) :114-126.
  • 7Brunzell JD, Davidson M, Furberg CD, et al. Lipoprotein management in patients with cardiometabolic risk: consensus statement from the American Diabetes Association and the American College of Cardiology Foundation [J]. Diabetes Care,2008,31 (4) :811-822.
  • 8Robins SJ, Collins D, Wittes JT, et al. Relation of gemfibrozil treatment and lipid levels with major coronary events: VA-HIT: a randomized controlled trial[J].JAMA, 2001, 285(12) :1585- 1591.
  • 9Barter PJ, Kastelein JJ. Targeting cholesteryl ester transfer protein for the prevention and management of cardiovascular disease[J]. J Am Coll Cardiol,2006,47(3) :492- 499.
  • 10Brown BG, Zhao XQ, Chait A, et al. Simvastatin and nia tin, antioxidant vitamins, or the combination for the preven tion of coronary disease[J].N Engl J Med, 2001,345 (22):1583-1592.

共引文献39

同被引文献7

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部